4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-022205
SVP, Diagnostics, immunoSEQ Dx sold 16,052 shares at an average $43.58 ($699,560)
- SVP, Diagnostics, immunoSEQ Dx acquired 16,052 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Palaniappan Jyoti SVP, Diagnostics, immunoSEQ Dx | 2021-03-18 | Option exercise | +16,052 | $22.55 | $361,973 | 25,210 | D: show line 1 in the form |
| Palaniappan Jyoti SVP, Diagnostics, immunoSEQ Dx | 2021-03-18 | Sale | −8,342 | $43.04 | $359,040 | 16,868 | D: show line 2 in the form |
| Palaniappan Jyoti SVP, Diagnostics, immunoSEQ Dx | 2021-03-18 | Sale | −5,971 | $43.83 | $261,709 | 10,897 | D: show line 3 in the form |
| Palaniappan Jyoti SVP, Diagnostics, immunoSEQ Dx | 2021-03-18 | Sale | −1,739 | $45.32 | $78,811 | 9,158 | D: show line 4 in the form |
| Open-market sales · 16,052 sh · avg $43.58 · $699,560 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Palaniappan Jyoti SVP, Diagnostics, immunoSEQ Dx | 2021-03-18 | Option exercise · Stock Option (Right to Buy) | −16,052 | 108,948 | D: show line 5 in the form |
Loading xslF345X03/doc4.xml…